Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and

Comparison of percentage total body weight loss (%TWL) between metabolic bariatric surgery and incretin-based pharmacotherapy in adults with type 2 diabetes mellitus. Forest plot showing pooled mean difference in percentage total body weight loss (%TWL) between treatment groups.

Medical Literature · Updated 2026-08-07

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.